Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

Non-curative Resectable Bile Duct Carcinoma Clinical Trial

Official title: A Phase II, Open-label, Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

Status Recruiting

Clinical Trial Summary

The purpose of this study is to assess efficacy and safety of Foscan (temoporfin) photodynamic therapy in the treatment of locally advanced perihilar bile duct carcinoma without distant metastases.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Bile Duct Neoplasms
• Carcinoma
• Carcinoma, Ductal
• Non-curative Resectable Bile Duct Carcinoma

• NCT number: NCT01016002
• Study type: Interventional
• Source: University of Salzburg
• Contact: Frieder Berr, Prof., MD
• Phone: (43-) 662-4482
• Email: f.berr@salk.at
• Status: Recruiting
• Phase: Phase 2
• Start date: January 2006